Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Chapron

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
British Journal of Clinical Pharmacology|June 1, 1989
Differential effects of flurbiprofen and aspirin on acetazolamide disposition in humansK R Sweeney, D J Chapron, E J Antal, et al.
Archives of Neurology|July 1, 1979
Effect of calcium and antacids on phenytoin bioavailabilityD J Chapron, P A Kramer, S L Mariano, et al.
The Journal of Pediatrics|April 1, 1988
Furosemide pharmacokinetics in very low birth weight infantsM H Mirochnick, J J Miceli, P A Kramer, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
Pharmacokinetics and dynamics of furosemide in the newborn pigletJ J Miceli, P A Kramer, D J Chapron, et al.
Developmental Pharmacology and Therapeutics|January 1, 1990
Renal response to furosemide in very low birth weight infants during chronic administrationM H Mirochnick, J J Miceli, P A Kramer, et al.
Journal of Clinical Psychopharmacology|June 1, 1982
Estimating steady state desipramine levels in noninstitutionalized elderly patients using single dose disposition parametersE J Antal, I R Lawson, L M Alderson, et al.
British Journal of Clinical Pharmacology|November 1, 1981
Theophylline pharmacokinetics in advanced ageE J Antal, P A Kramer, S A Mercik, et al.
Journal of Clinical Psychopharmacology|February 1, 1982
Imipramine disposition in alcoholicsD A Ciraulo, L M Alderson, D J Chapron, et al.
Clinical Pharmacology and Therapeutics|November 1, 1986
Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanationK R Sweeney, D J Chapron, J L Brandt, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
British Journal of Clinical Pharmacology|June 1, 1989
Differential effects of flurbiprofen and aspirin on acetazolamide disposition in humansK R Sweeney, D J Chapron, E J Antal, et al.
Archives of Neurology|July 1, 1979
Effect of calcium and antacids on phenytoin bioavailabilityD J Chapron, P A Kramer, S L Mariano, et al.
The Journal of Pediatrics|April 1, 1988
Furosemide pharmacokinetics in very low birth weight infantsM H Mirochnick, J J Miceli, P A Kramer, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
Pharmacokinetics and dynamics of furosemide in the newborn pigletJ J Miceli, P A Kramer, D J Chapron, et al.
Developmental Pharmacology and Therapeutics|January 1, 1990
Renal response to furosemide in very low birth weight infants during chronic administrationM H Mirochnick, J J Miceli, P A Kramer, et al.
Journal of Clinical Psychopharmacology|June 1, 1982
Estimating steady state desipramine levels in noninstitutionalized elderly patients using single dose disposition parametersE J Antal, I R Lawson, L M Alderson, et al.
British Journal of Clinical Pharmacology|November 1, 1981
Theophylline pharmacokinetics in advanced ageE J Antal, P A Kramer, S A Mercik, et al.
Journal of Clinical Psychopharmacology|February 1, 1982
Imipramine disposition in alcoholicsD A Ciraulo, L M Alderson, D J Chapron, et al.
Clinical Pharmacology and Therapeutics|November 1, 1986
Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanationK R Sweeney, D J Chapron, J L Brandt, et al.
Pageof 3